Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 26;5(2):bjgpopen20X101140.
doi: 10.3399/bjgpopen20X101140. Print 2021 Apr.

Treatment of uncomplicated UTI in males: a systematic review of the literature

Affiliations

Treatment of uncomplicated UTI in males: a systematic review of the literature

Karen Farrell et al. BJGP Open. .

Abstract

Background: Urinary tract infections (UTIs) affect around 20% of the male population in their lifetime. The incidence of UTIs in men in the community is 0.9-2.4 cases per 1000 aged <55 years and 7.7 per 1000 aged ≥85 years.

Aim: To evaluate the outcomes of randomised controlled trials (RCTs) comparing the effectiveness of different antimicrobial treatments and durations for uncomplicated UTIs in adult males in outpatient settings.

Method: A systematic literature review of RCTs of adult male patients with an uncomplicated UTI treated with oral antimicrobials in any outpatient setting. The outcomes were symptom resolution within 2 weeks of starting treatment, duration until symptom resolution, clinical cure, bacteriological cure, and frequency of adverse events.

Results: From the 1052 abstracts screened, three provided sufficient information on outcomes. One study compared trimethoprim-sulfamethoxazole for 14 days (21 males) with 42 days (21 males). Fluoroquinolones were compared in the two other RCTs: lomefloxacin (10 males) with norfloxacin (11 males), and ciprofloxacin for 7 days (19 males) and 14 days (19 males). Combining the results from the three RCTs shows that for 75% males with a UTI (76/101) bacteriological cure was reported at the end of the study. Of the 59 patients receiving a fluoroquinolone, 57 (97%) reported bacteriological and clinical cure within 2 weeks after treatment.

Conclusion: The evidence available is insufficient to make any recommendations in relation to type and duration of antimicrobial treatment for male UTIs. Sufficiently powered RCTs are needed to identify best treatment type and duration for male UTIs in primary care.

Keywords: antibiotic treatment; male; primary health care; randomised clinical trial; review; urinary tract infections.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. PRISMA flow diagram. RCT = randomised controlled trial; UTI = urinary tract infection.

References

    1. Brumfitt W, Hamilton-Miller JM, Gillespie WA. The mysterious 'urethral syndrome'. BMJ. 1991;303(6804):719–720. doi: 10.1136/bmj.303.6804.719-c. - DOI - PMC - PubMed
    1. Griebling TL. Urologic diseases in America project: trends in resource use for urinary tract infections in men. J Urol. 2005;173(4):1288–1294. doi: 10.1097/01.ju.0000155595.98120.8e. - DOI - PubMed
    1. Lark RL, Saint S, Chenoweth C, et al. Four-Year prospective evaluation of community-acquired bacteremia: epidemiology, microbiology, and patient outcome. Diagn Microbiol Infect Dis. 2001;41(1-2):15–22. doi: 10.1016/S0732-8893(01)00284-X. - DOI - PubMed
    1. Tal S, Guller V, Levi S, et al. Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection. J Infect. 2005;50(4):296–305. doi: 10.1016/j.jinf.2004.04.004. - DOI - PubMed
    1. Car J. Urinary tract infections in women: diagnosis and management in primary care. BMJ. 2006;332(7533):94–97. doi: 10.1136/bmj.332.7533.94. - DOI - PMC - PubMed

LinkOut - more resources